PM012-2b, NCT05811000: A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease |
|
|
| Recruiting | 2/3 | 312 | RoW | PM012, PM012 Placebo, Donepezil, Donepezil placebo | Mediforum Ltd., Co., LSK Global Pharma Services Co. Ltd. | Mild Alzheimer Disease | 02/21 | 08/24 | | |